Implementierungsleitfaden Therapieziele Onkologie - Local Development build (v1.0.0-ballot) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

• Narrativer Inhalt
• XML
• JSON

: Adjuvante Systemtherapie – Pembrolizumab-Monotherapie (KEYNOTE-522, Beispiel)

Raw json | Download

{
  "resourceType" : "MedicationRequest",
  "id" : "MedicationRequestPembroAdjuvantMamma",
  "meta" : {
    "profile" : [
      🔗 "https://bih-cei.de/fhir/therapieziele-onkologie/StructureDefinition/onko-tumorboard-medication-request"
    ]
  },
  "language" : "de",
  "text" : {
    "status" : "extensions",
    "div" : "<div xml:lang=\"de\" lang=\"de\"><hr/><p><b>German</b></p><hr/><p class=\"res-header-id\"><b>Generated Narrative: MedicationRequest MedicationRequestPembroAdjuvantMamma</b></p><a name=\"MedicationRequestPembroAdjuvantMamma\"> </a><a name=\"hcMedicationRequestPembroAdjuvantMamma\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-onko-tumorboard-medication-request.html\">Tumorboard MedicationRequest</a></p></div><p><b>EnLiST-Änderungstyp (Extension)</b>: <span title=\"Codes:{https://bih-cei.de/fhir/therapieziele-onkologie/CodeSystem/enlist-change-type same}\">Same LoT</span></p><p><b>status</b>: Active</p><p><b>intent</b>: Plan</p><p><b>category</b>: <span title=\"Codes:{http://loinc.org 85232-7}\">Tumor board Consult note</span></p><p><b>medication</b>: <span title=\"Codes:\">Pembrolizumab-Monotherapie (adjuvant, KEYNOTE-522), ambulant, ~9 Zyklen q3w</span></p><p><b>subject</b>: <a href=\"Patient-PatientinMamma.html\">Sabine Baumann  Female, DoB: 1977-06-24</a></p></div>"
  },
  "extension" : [
    {
      "url" : "https://bih-cei.de/fhir/therapieziele-onkologie/StructureDefinition/enlist-change",
      "valueCodeableConcept" : {
        "coding" : [
          {
            "system" : "https://bih-cei.de/fhir/therapieziele-onkologie/CodeSystem/enlist-change-type",
            "code" : "same",
            "display" : "Same LoT"
          }
        ]
      }
    }
  ],
  "status" : "active",
  "intent" : "plan",
  "category" : [
    {
      "coding" : [
        {
          "system" : "http://loinc.org",
          "code" : "85232-7",
          "display" : "Tumor board Consult note"
        }
      ]
    }
  ],
  "medicationCodeableConcept" : {
    "text" : "Pembrolizumab-Monotherapie (adjuvant, KEYNOTE-522), ambulant, ~9 Zyklen q3w"
  },
  "subject" : {
    🔗 "reference" : "Patient/PatientinMamma"
  }
}